Erica My Tran
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Erica My Tran’s office at (408) 371-9010 to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$92,282
Medicare paid this office $92,282 for 715 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 426 | $33,462 | $68 |
| Return visit (30+ min) | 171 | $18,753 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 92 | $12,322 | $134 |
| Sarscov2 vac 50 mcg/0.5ml im | 40 | $6,183 | $155 |
| Influenza vaccine split virus, preservative free | 69 | $5,636 | $82 |
See all 12 services
| Short return visit (20+ min) | 426 | $33,462 | $68 |
| Return visit (30+ min) | 171 | $18,753 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 92 | $12,322 | $134 |
| Sarscov2 vac 50 mcg/0.5ml im | 40 | $6,183 | $155 |
| Influenza vaccine split virus, preservative free | 69 | $5,636 | $82 |
| Administration of influenza virus vaccine | 75 | $2,867 | $38 |
| Admn sarscov2 vacc 1 dose | 51 | $2,761 | $52 |
| Sarscv2 vac 30mcg trs-suc im | 13 | $1,913 | $147 |
| Short return visit | 32 | $1,255 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 50 | $608 | $12 |
| Removal of impacted ear wax by washing | 14 | $203 | $14 |
| Automated urinalysis test | 33 | $77 | $2 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
715 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 22% · Women 61% · Also on Medicaid 7% · Health risk score 1.27. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 31% · Diabetes 25% · Chronic kidney disease 23% · Cancer 21% · Atrial fibrillation 21% · Depression 19% · Heart failure 15% · COPD 13% · Stroke 13% · Dementia 9%.
The office billed $350,462, Medicare allowed $113,140 and paid $92,282; for 1,255 services of 38 kinds; $15,806 of it was for drugs given in the office and $76,476 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 715 | 1,255 | 78 | 1.27 | $350,462 | $92,282 |
| 2023 | 73 | 91 | 78 | 1.26 | $29,569 | $7,033 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 37 | $2,809 | $74 |
| Return visit (30+ min) | 22 | $2,392 | $104 |
Medicaid work
$697,720 in 2023
Medicaid paid $697,720 for 4,978 billed services this clinician did in 2023, up to 279 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,090 | $692,924 |
| Short return visit (20+ min) | 1,184 | $2,838 |
| Short return visit | 1,017 | $1,188 |
| New patient visit (30+ min) | 181 | $770 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 99 | $0 |
| Return visit (30+ min) | 79 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 194 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 134 | $0 |
| 2023 | 4,978 | 8 | 279 | $697,720 |
| 2022 | 6,003 | 11 | 348 | $780,586 |
| 2021 | 869 | 6 | 211 | $99,240 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 2,396 | $779,873 |
| Short return visit (20+ min) | 1,710 | $552 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 159 | $161 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 14 | $0 |
| Bilateral quantitative screening test of visual acuity | 30 | $0 |
| New patient visit (30+ min) | 91 | $0 |
| Short return visit | 970 | $0 |
| Return visit (30+ min) | 241 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 240 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 117 | $0 |
| Screening for depression is documented as negative, a follow-up plan is not required | 35 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 355 | $99,168 |
| Short return visit (20+ min) | 318 | $72 |
| Bilateral quantitative screening test of visual acuity | 12 | $0 |
| Short return visit | 86 | $0 |
| Return visit (30+ min) | 86 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 12 | $0 |
Drugs they prescribed that Part D paid
$410,845
Pharmacies billed $410,845 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (63 of 6,501) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
5,899 generic and 566 brand-name prescriptions · $410,845 in drug cost · 135 antibiotic prescriptions to 114 people · 25 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 91 | $98,050 | $1,077 |
| Jardiance | 29 | $43,582 | $1,503 |
| Xarelto | 18 | $26,387 | $1,466 |
| Januvia | 16 | $20,981 | $1,311 |
| Janumet | 12 | $11,132 | $928 |
See all 105 drugs
| Eliquis | 91 | $98,050 | $1,077 |
| Jardiance | 29 | $43,582 | $1,503 |
| Xarelto | 18 | $26,387 | $1,466 |
| Januvia | 16 | $20,981 | $1,311 |
| Janumet | 12 | $11,132 | $928 |
| Anoro Ellipta | 11 | $6,566 | $597 |
| Advair Hfa | 20 | $6,280 | $314 |
| Synthroid | 61 | $5,566 | $91 |
| Atorvastatin | 504 | $4,959 | $10 |
| Levothyroxine | 347 | $4,221 | $12 |
| Losartan | 331 | $4,011 | $12 |
| Rosuvastatin | 129 | $3,645 | $28 |
| Amlodipine Besylate | 368 | $3,283 | $9 |
| Gabapentin | 132 | $2,629 | $20 |
| Metoprolol | 166 | $2,365 | $14 |
| Wixela Inhub | 22 | $2,266 | $103 |
| Tamsulosin | 127 | $2,151 | $17 |
| Pantoprazole | 133 | $2,016 | $15 |
| Albuterol Sulfate Hfa | 64 | $1,932 | $30 |
| Omeprazole | 128 | $1,795 | $14 |
| Lisinopril | 198 | $1,740 | $9 |
| Metformin | 131 | $1,548 | $12 |
| Simvastatin | 155 | $1,448 | $9 |
| Fluticasone-Salmeterol | 11 | $1,385 | $126 |
| Nebivolol | 25 | $1,292 | $52 |
| Potassium Chloride | 51 | $1,155 | $23 |
| Ezetimibe | 32 | $1,114 | $35 |
| Escitalopram | 69 | $1,102 | $16 |
| Pravastatin | 77 | $1,028 | $13 |
| Allopurinol | 95 | $992 | $10 |
| Oxybutynin Chloride Er | 24 | $945 | $39 |
| Bupropion Xl | 36 | $933 | $26 |
| Sertraline | 82 | $859 | $10 |
| Valsartan | 25 | $841 | $34 |
| Azelastine | 24 | $840 | $35 |
| Mirtazapine | 29 | $810 | $28 |
| Celecoxib | 31 | $803 | $26 |
| Alendronate | 73 | $783 | $11 |
| Montelukast | 58 | $778 | $13 |
| Diltiazem 24hr Er (Cd) | 22 | $753 | $34 |
| Diclofenac | 47 | $750 | $16 |
| Nifedipine Er | 11 | $702 | $64 |
| Clopidogrel | 59 | $687 | $12 |
| Baclofen | 23 | $655 | $28 |
| Losartan-Hydrochlorothiazide | 35 | $640 | $18 |
| Zolpidem | 57 | $634 | $11 |
| Fluoxetine | 27 | $620 | $23 |
| Olmesartan Medoxomil | 37 | $613 | $17 |
| Venlafaxine Hcl Er | 21 | $572 | $27 |
| Famotidine | 51 | $552 | $11 |
| Hydrocodone-Acetaminophen | 28 | $535 | $19 |
| Colchicine | 16 | $528 | $33 |
| Finasteride | 41 | $523 | $13 |
| Trazodone | 74 | $523 | $7 |
| Glipizide Er | 22 | $519 | $24 |
| Paroxetine | 25 | $505 | $20 |
| Metformin Hcl Er | 72 | $491 | $7 |
| Ipratropium | 13 | $464 | $36 |
| Hydrochlorothiazide | 123 | $448 | $4 |
| Furosemide | 58 | $444 | $8 |
| Terazosin | 11 | $434 | $39 |
| Nystatin | 23 | $425 | $18 |
| Atenolol | 59 | $421 | $7 |
| Verapamil Er | 23 | $414 | $18 |
| Benazepril | 24 | $406 | $17 |
| Duloxetine | 25 | $402 | $16 |
| Citalopram Hbr | 31 | $379 | $12 |
| Ramipril | 27 | $340 | $13 |
| Fluticasone Propionate | 35 | $339 | $10 |
| Klor-Con M20 | 13 | $338 | $26 |
| Triamterene-Hydrochlorothiazid | 22 | $335 | $15 |
| Metoprolol | 33 | $327 | $10 |
| Ropinirole | 13 | $310 | $24 |
| Hydralazine | 23 | $300 | $13 |
| Doxazosin Mesylate | 25 | $287 | $11 |
| Valacyclovir | 17 | $284 | $17 |
| Lovastatin | 27 | $284 | $11 |
| Amoxicillin-Clavulanate Potass | 32 | $282 | $9 |
| Amitriptyline | 16 | $267 | $17 |
| Quetiapine | 12 | $257 | $21 |
| Donepezil | 17 | $248 | $15 |
| Cyclobenzaprine | 16 | $240 | $15 |
| Klor-Con 10 | 13 | $237 | $18 |
| Spironolactone | 21 | $234 | $11 |
| Valsartan-Hydrochlorothiazide | 14 | $225 | $16 |
| Carvedilol | 21 | $219 | $10 |
| Hydroxyzine | 18 | $213 | $12 |
| Meloxicam | 49 | $204 | $4 |
| Lisinopril-Hydrochlorothiazide | 34 | $198 | $6 |
| Ketoconazole | 12 | $193 | $16 |
| Triamcinolone Acetonide | 27 | $188 | $7 |
| Glipizide | 21 | $179 | $9 |
| Nitrofurantoin Mono-Macro | 17 | $176 | $10 |
| Ondansetron Odt | 15 | $157 | $10 |
| Cephalexin | 21 | $147 | $7 |
| Ibuprofen | 13 | $133 | $10 |
| Tramadol | 18 | $128 | $7 |
| Pioglitazone | 18 | $115 | $6 |
| Lorazepam | 16 | $105 | $7 |
| Fluconazole | 16 | $95 | $6 |
| Insulin | 12 | $88 | $7 |
| Azithromycin | 13 | $62 | $5 |
| Prednisone | 16 | $59 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $43 | $4 |
| Paxlovid | 15 | $0 | $0 |
Year by year
| 2024 | 6,501 | 1,570 | 1% (63) | 9% | $410,845 |
| 2023 | 758 | 309 | None | None | $64,569 |
| 2022 | 928 | 184 | None | None | $73,277 |
| 2021 | 64 | 29 | 0% (0) | 19% | $3,063 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Diclofenac | 11 | $7,201 | $655 |
| Albuterol Sulfate Hfa | 23 | $875 | $38 |
| Gabapentin | 32 | $609 | $19 |
| Atorvastatin | 37 | $432 | $12 |
| Famotidine | 18 | $375 | $21 |
| Levothyroxine | 27 | $374 | $14 |
| Amlodipine Besylate | 39 | $306 | $8 |
| Lisinopril | 24 | $267 | $11 |
| Losartan | 20 | $181 | $9 |
| Omeprazole | 11 | $170 | $15 |
| Fluticasone Propionate | 18 | $158 | $9 |
| Pantoprazole | 14 | $146 | $10 |
| Ibuprofen | 11 | $93 | $8 |
| Furosemide | 20 | $81 | $4 |
| Hydroxyzine Pamoate | 14 | $60 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $41 | $4 |
2022: 22 drugs
| Albuterol Sulfate Hfa | 30 | $1,471 | $49 |
| Gabapentin | 32 | $1,379 | $43 |
| Omeprazole | 27 | $692 | $26 |
| Atorvastatin | 47 | $611 | $13 |
| Lisinopril | 47 | $598 | $13 |
| Amlodipine Besylate | 39 | $384 | $10 |
| Famotidine | 20 | $372 | $19 |
| Amoxicillin-Clavulanate Potass | 18 | $297 | $16 |
| Levothyroxine | 18 | $272 | $15 |
| Losartan | 17 | $252 | $15 |
| Nitrofurantoin Mono-Macro | 11 | $251 | $23 |
| Hydroxyzine | 13 | $251 | $19 |
| Fluticasone Propionate | 17 | $236 | $14 |
| Ibuprofen | 14 | $232 | $17 |
| Simvastatin | 11 | $220 | $20 |
| Metformin | 21 | $212 | $10 |
| Furosemide | 22 | $146 | $7 |
| Azithromycin | 14 | $120 | $9 |
| Glipizide | 14 | $103 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $101 | $6 |
| Metoprolol | 11 | $55 | $5 |
| Hydrochlorothiazide | 11 | $33 | $3 |
Money from drug and device companies
$24 in 2025
| 2025 | 1 | 1 | None | $24 |
| 2024 | 1 | 1 | None | $28 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
See the published payment
| Exact Sciences | Meals · 2025-02-26 | Cologuard Collection Kit | $24 |
See earlier years (2024)
2024: $28
| GlaxoSmithKline | Arexvy | $28 | 1 payment
|
Professional record
- NPI
- 1376160697
- Licence
- CA 95018643
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 2410 Samaritan Dr Ste 201, San Jose, CA, 95124
- NPI first listed
- 2020-07-02
- NPI last updated
- 2023-11-13
- NPI record certified
- 2023-11-13
This is when the NPI record was last certified, not a medical board exam.